Publication

Connexins: Synthesis, Post-Translational Modifications, and Trafficking in Health and Disease

Downloadable Content

Persistent URL
Last modified
  • 05/23/2025
Type of Material
Authors
    Trond Aasen, Autonomous University of BarcelonaScott Johnstone, University of VirginiaLaia Vidal-Brime, Autonomous University of BarcelonaK. Sabrina Lynn, Emory UniversityMichael H Koval, Emory University
Language
  • English
Date
  • 2018-05-01
Publisher
  • MDPI
Publication Version
Copyright Statement
  • © 2018 by the authors. Licensee MDPI, Basel, Switzerland.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1661-6596
Volume
  • 19
Issue
  • 5
Start Page
  • 1296
End Page
  • 1296
Grant/Funding Information
  • Supported by NIH R01-AA025854 and R01-HL137112 (Michael Koval) and F31-HL139109 (K. Sabrina Lynn).
  • Trond Aasen acknowledges support from Instituto de Salud Carlos III grants PI13/00763, PI16/00772 and CPII16/00042, co-financed by the European Regional Development Fund (ERDF).
Abstract
  • Connexins are tetraspan transmembrane proteins that form gap junctions and facilitate direct intercellular communication, a critical feature for the development, function, and homeostasis of tissues and organs. In addition, a growing number of gap junction-independent functions are being ascribed to these proteins. The connexin gene family is under extensive regulation at the transcriptional and post-transcriptional level, and undergoes numerous modifications at the protein level, including phosphorylation, which ultimately affects their trafficking, stability, and function. Here, we summarize these key regulatory events, with emphasis on how these affect connexin multifunctionality in health and disease.
Author Notes
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery
  • Health Sciences, Pathology

Tools

Relations

In Collection:

Items